(Q61934614)
Statements
A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering From Restless Legs Syndrome (RLS) (English)
0 references
August 2003
0 references
May 2004
0 references
360
0 references
18 year
0 references
79 year
0 references